UPDATE: Dendreon Announces Prelim. Data for PROVENGE Shows Positive ...
Benzinga
Data from an open-label study demonstrate the presence of existing immunological memory in advanced prostate cancer patients retreated with PROVENGE several years after initial treatment for androgen dependent prostate cancer (ADPC) in the Phase III ...